Selexis CHO Cells in Suspension-1


Selexis works with innovative partners world wide. Large or small biotech, private or public. Under strict confidentiality. Selexis cell lines will add value to our partners programs as it is considered an asset when it comes to licensing

Our timelines and innovation are unprecedented. This is our focus, which is why we do it best. Ultimately, we help companies get drugs to patients faster and more cost-effectively.

With the ability to express any recombinant protein, including difficult-to-express proteins, Selexis is proud to have partnered with the following companies, and others, supporting the development of innovative therapies across a range of diseases: